Aim: To compare perinatal outcomes for neonates conceived with donated sperm with those for neonates conceived spontaneously in an Australian population cohort. Methods: Perinatal outcomes for all births in South Australia for the period January 1986-December 2002 were linked with assisted reproductive treatment records to determine those conceived from donated sperm. Birth outcome measures were analyzed using Student's t-test and logistic regression using generalized estimating equations to determine statistical significance. Results: Donor sperm neonates were not significantly different from their spontaneously conceived counterparts in terms of mean birthweight, low birthweight, preterm delivery, small for gestational age, or large for gestational age. They were, however, significantly more likely to be born at lower mean gestational age (P = 0.012), and to have preterm delivery with low birthweight (P = 0.008), when controlling for maternal age, parity, ethnicity, socioeconomic quartile and baby's sex. These associations were not apparent when singletons and twins were considered separately. Conclusion: There was some evidence of compromised perinatal outcomes for donor sperm neonates compared with their spontaneously conceived counterparts, which appeared to be partly attributable to multiplicity.
Introduction
Pregnancy rates achieved through the use of donor sperm have been reported extensively, [1] [2] [3] [4] [5] [6] [7] [8] but pregnancy is not the only important outcome to account for in clinical practice. The health of the child born is also of significant importance. Given that poor perinatal outcomes have been linked with poor adult health through the fetal origins of adult disease hypothesis, 9 the health of the newborn can potentially influence the health trajectory of the person in adulthood. Thus the perinatal outcomes for neonates conceived with donated sperm provide crucial evidence not only of the efficacy of the treatment to produce a live birth, but also its potential impact on the health of the person perinatally as well as in the long term.
A systematic review comparing perinatal outcomes among donor sperm neonates with those conceived spontaneously found that studies published up until November 2012 were not only scarce, but inadequate for a comprehensive meta-analysis, due to a lack of studies with an appropriate comparison group. 10 The review did not find any evidence of increased or decreased prevalence of low-birthweight (LBW < 2500 g), preterm delivery (PD < 37 weeks), or birth defects (BD) in the donor sperm-conceived group compared with spontaneous conceptions. 10 The lack of available studies for meta-analysis, however, means that caution must be exercised when interpreting these findings. Individual studies included in the review, however, raised concerns about the possibility of increased chromosomal abnormalities in donor sperm neonates, which was potentially linked with the use of cryopreserved sperm. Furthermore, given that only three outcome categories could be meta-analyzed, any future studies should address a greater variety of outcome measures.
We have previously observed an increase in the risk of birth defects among singletons born from donor sperm that was attenuated after adjustment for maternal factors (unadjusted odds ratio [OR], 1.51; 95 %CI: 1.08-2.11; adjusted OR, 1.37; 95%CI: 0.98-1.92). 11 This observation raises the question as to whether there are accompanying, but less severe, adverse outcomes associated with donor sperm.
The use of donor sperm does provide mechanisms through which perinatal outcomes may be adversely affected. First, since the advent of the AIDS (HIV) epidemic in the 1980s, donor sperm has been exclusively cryopreserved in many Western jurisdictions. 10, 12 Cryopreservation of sperm introduces oxidative stress, which increases DNA fragmentation rates. [13] [14] [15] Children conceived with oxidative stress-induced DNA-damaged sperm are at increased risk of childhood morbidity. 16, 17 Second, donor sperm represents an immunological challenge to the woman that may lead to increased occurrence of pre-eclampsia (PE). [18] [19] [20] [21] [22] PE represents a significant morbidity and mortality burden to not only the mother, but also to the fetus. [23] [24] [25] In the perinatal period, PE leads to increased occurrence of PD, 26 and even when controlling for PD it has been associated with an increased risk of being born small for gestational age (SGA), or the neonate having respiratory distress syndrome, apnea, asphyxia, peri-or intra-ventricular hemorrhage, and increased neonatal intensive care unit admissions. 27 Maternal PE is also associated with poorer health outcomes when the child reaches adolescence and adulthood such as increased incidences of cardiovascular disease, 23 hypertension, 28 stroke, 29 lower hip bone mass density, 30 and higher body mass index. 31 In contrast to donor sperm-related perinatal outcomes, donor oocyte perinatal outcomes have been more thoroughly investigated. Meta-analysis within a systematic review has shown that donor oocyte neonates in comparison with autologous oocyte neonates (autologous in vitro fertilization [IVF] ) are at significantly increased risk of being born LBW (no. studies in metaanalysis, 15), very LBW (VLBW <1500 g, n = 11), PD (n = 13), PD with LBW (n = 11), and of lower gestational age (n = 3). 32 They were also at decreased risk of being born at term and LBW (n = 11). 32 Additionally, a further systematic review and meta-analysis by Jeve et al., concluded that donor oocyte neonates were at increased risk of being born SGA (n = 6), PD (n = 9), are more likely to be delivered by cesarean section (n = 6), and were more likely to have mothers with hypertensive disorders (n = 10), including PE (N = 4), when compared with autologous oocyte neonates. 33 The number of studies that were included in the donor oocyte meta-analyses is larger than the number included in the donor sperm meta-analysis, thereby highlighting the need for further well designed donor sperm perinatal studies.
It is therefore both pertinent and imperative that further studies are conducted on the perinatal outcomes of donor sperm-conceived neonates in comparison with spontaneously conceived neonates. Population-based studies will not only increase knowledge of any impact on offspring of donor sperm use, but also increase confidence in the analysis of the effects of the sperm donation treatment on perinatal outcomes. Such information is valuable to clinicians to allow them to fully inform their patients on the potential health outcomes for any child conceived using donated sperm.
Methods
Ethics approval for this study was obtained from the Flinders University Social and Behavioural Research Ethics Committee and is in accordance with the Declaration of Helsinki (as revised in Tokyo 2004). Consent from the participants was not required by the ethics committee because data were already recorded in a database. Approval for access to the perinatal data was provided by the University of Adelaide, Flinders University, and the South Australian Department of Health Ethics Committees.
Study design
In South Australia all births are recorded in the South Australian Perinatal Statistics Collection (SAPSC) as required by law, enabling a population-wide retrospective cohort study. The collection was linked to clinical data for those conceived through assisted reproductive technology (ART), including conceptions from donor sperm. The perinatal outcomes of neonates conceived using donor sperm were compared with that of spontaneously conceived neonates. The reporting of all births (live and stillbirth; SB), for outcomes of at least 20 weeks' gestation or with birthweight ≥400 g, is mandatory. A standardized notification form is used to provide consistency in reporting. Furthermore, it is also mandatory in South Australia to report medical terminations of pregnancy. Those occurring at 20 weeks of gestation or later are included in the SAPSC. The SAPSC also contains data on potential confounders such as maternal sociodemographic variables (age, ethnicity, socioeconomic status) and maternal pre-existing medical conditions (hypertension, diabetes, asthma, and epilepsy), in addition to those occurring during pregnancy (pregnancy-induced hypertension [PIH] , and gestational diabetes).
Participants
The participants were all neonates born in the State of South Australia between January 1986 and December 2002. Those neonates conceived through alternative ART modalities that are not donor sperm such as donor oocytes, donor embryos, various forms of IVF, and intracytoplasmic sperm injection (ICSI), however, were excluded. Donor sperm neonates include those from standard donor insemination programs and those in which IVF had previously failed, but did not include gamete intra-fallopian transfer with donor sperm, or IVF with donor sperm.
Outcome variables
Birthweight and gestational age were analyzed as continuous variables. Several dichotomous outcomes were also considered: PD (< 37 weeks), very PD (VPD; <32 weeks), post-term delivery (PostD; >41 weeks), LBW (<2500 g), very LBW (VLBW; <1500 g), PD with LBW, term delivery (TD) with LBW, Apgar score <7 at 5 min (5'AS < 7), SGA (birthweight < 10th percentile), 36 large for gestational age (LGA; birthweight > 90th percentile), 36 neonatal death (death within the 28 days following birth), and SB.
Statistical analysis
Continuous variables that were normally distributed were summarized using means and standard deviation, and then subjected to two-tailed, Student's t-test to determine if differences according to mode of conception were statistically significant. For dichotomous outcomes, chi-squared tests were used to assess differences, and logistic regression analysis using generalized estimating equations was undertaken to produce OR and 95%CI. Results were deemed to be significant for P < 0.05. All statistical analysis was conducted using Stata V.14. (StataCorp, College Station, Texas, USA).
Higher order multiples of triplets and above were excluded from the spontaneously conceived cohort (n = 384), because there were no higher order multiples present in the donor sperm cohort. Thus analysis was restricted to singletons and twins. Births recorded to mothers under 20 years of age were excluded from the study because only one such case of a mother receiving donor insemination treatment was recorded. Babies of indeterminate or unknown sex (n = 309) were excluded from the spontaneously conceived cohort because there were none in the donor sperm cohort. Data on the zygosity of twins were not available.
Effect estimates were adjusted for the following a priori confounders of maternal age (categorized in 5-year age groups): parity, socioeconomic disadvantage on the basis of the postal code of the mother's residence (according to the Socio-economic Indexes for Areas (SEIFA) 37 ), maternal race or ethnic group and fetal sex. Using the change in estimate approach, 38 maternal conditions of pre-existing hypertension, PIH, pre-existing diabetes, gestational diabetes, epilepsy, asthma, and anemia were included in the fully adjusted model if their inclusion produced > ±10 % change in the main effect estimate. PIH was the term used in the SAPSC for the period of the study, but is now known as hypertensive disorders of pregnancy. Analyses were conducted for all births, then stratified by multiplicity. All OR account for clustering within mother, i.e. births resulting from multiple gestations or serial pregnancies to the same woman, which cannot be treated as independent observations in statistical analyses. During the study period a proportion of artificial insemination with donor sperm treatments were performed with ovulation induction (OI). To assess any impact of OI, birth outcomes for OI cycles were compared with those for natural cycles within the cohort.
Further adjustment for maternal conditions in pregnancy (pre-existing hypertension, PIH, pre-existing diabetes, gestational diabetes, epilepsy, asthma, anemia), did not produce any change in the effect estimates and are therefore not presented. Due to sparse data, OR could not be calculated for the outcomes of VPD, PostD, VLBW, TD with LBW, and 5'AS < 7 in any stratified groups, or for SGA and LGA in twins, but the data were included for reference.
Results
All births from January 1986 to December 2002 totaled 299 424, of which there were 297 756 live births (including 939 neonatal deaths) and 1668 SB. Characteristics of these births according to mode of conception and birth outcome are listed in Table 1 .
With regard to live births, mothers of donor spermconceived neonates were in general older than their counterparts who conceived spontaneously. There were greater percentages of births from donor sperm in all maternal age groups >30 years. Mothers receiving donor sperm were significantly more likely to be primigravid (P < 0.001), and nulliparous (P < 0.001). No statistically significant differences were observed between spontaneous and donor sperm births for socioeconomic status as analyzed by quartiles, but mothers using donor sperm were more likely to be Caucasian (P = 0.001).
A higher percentage of neonates from donor sperm were male, while a higher percentage of spontaneously conceived neonates were female, although these differences were non-significant. A significantly higher proportion of neonates from donor sperm were twins (P < 0.001). Mothers of neonates from donor sperm were significantly more likely to have PIH as well as pre-existing diabetes (both P = 0.027) compared with their spontaneously conceiving maternal counterparts. The occurrence of PIH was not significantly elevated among women with donor sperm-conceived twin deliveries (P = 0.116), but was significantly elevated among those with donor sperm-conceived singleton deliveries (P = 0.007; data not shown). Data for SB and neonatal death, are presented in Table 2 . There was no significant difference between births conceived with donor sperm and those conceived spontaneously for risk of SB. Twins in both conception groups had higher proportions of SB compared with singletons (2.3% vs 0.7% donor sperm; 2.0% vs 0.5% spontaneously conceived). No neonatal deaths occurred among neonates conceived via donor sperm, whereas the prevalence of neonatal death among spontaneously conceived neonates was 0.3% for singletons and 1.9% for twins.
Perinatal outcomes of all live births, then stratified into singletons and twins, are presented in Table 3 . Birthweight showed no statistically significant difference between conception groups overall and when singletons and twins were considered separately. Donor spermconceived neonates were more likely to be born at a lower gestational age than spontaneously conceived neonates (mean difference, À0.25 weeks; 95%CI: À0.45 to À0.06, P = 0.012). When singletons and twins were considered separately, however this was no longer statistically significant (singletons mean difference, À0.13 weeks; 95%CI: À0.31 to 0.05; twins mean difference, 0.51 weeks; 95%CI: À0.34 to 1.36).
Overall, donor sperm-conceived neonates were more likely to be born PD with LBW compared with spontaneously conceived neonates (7.1% vs 3.8%; OR, 1.74; 95% CI: 1.16-2.61, P = 0.008). When singletons and twins were considered separately, the differences were no longer statistically significant for singletons (4.2% vs 3.0%; OR, 1.37; 95%CI: 0.84-2.23), or twins (37.2% vs 37.2%; OR, 0.95; 95%CI: 0.42-2.13).
When PD was considered as a separate outcome, donor sperm neonates had a non-significant increased risk in comparison with spontaneously conceived neonates (9.5% vs 6.5%; OR, 1.34; 95%CI: 0.92-1.93), but no differences were observed for singletons ( The effect of OI on perinatal outcomes among donor sperm conceptions is presented in Table 4 . OI was associated with twin pregnancy (10.0% vs 2.1%, P < 0.001). Among all donor sperm births, OI was associated with a lower mean birthweight (P = 0.033), lower mean gestational age (P = 0.025), and increased occurrence of PD (P = 0.011), and PD with LBW (P = 0.021). When singletons and twins were considered separately, the only association that persisted was lower mean gestational age for OI twins when compared with natural cycle twins (P = 0.038).
Discussion
This study represents a comprehensive analysis of perinatal outcomes of neonates conceived with cryopreserved donated sperm in a population. Despite the potential for adverse perinatal outcomes due to the increased occurrence of PE and oxidative stress-induced DNA fragmentation reported elsewhere, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] significantly increased adverse outcomes were generally not observed in this cohort. There were, however, two exceptions. For all donor sperm births, mean gestational age was significantly lower and the likelihood of PD combined with LBW was significantly higher compared with spontaneously conceived births, after adjusting for maternal age, parity, ethnicity, socioeconomic quartile and sex of the neonate. These were no longer significant when singletons and twins were analyzed separately. Given the effect of stratifying by multiplicity on the number of events (≤24 events) in each group OR account for clustering within mother, i.e. births resulting from multiple gestations or serial pregnancies to the same woman, which cannot be treated as independent observations in statistical analyses, and are adjusted for maternal age, parity, ethnicity, socioeconomic quartile and baby's sex. †Twenty-four spontaneously conceived births were missing birthweight information. ‡Chi-squared
P-values.
OR and 95%CI could not be calculated due to sparse data. 5'AS < 7, Apgar score <7 at 5min; LBW, low-birthweight (<2500 g);
LGA, large for gestational age (>90th percentile) 36 ; PD, preterm delivery (<37 weeks' gestation); postD, post-term delivery (>41 weeks); SGA, small for gestational age (<10th percentile) 36 ; TD, term delivery; VLBW, very LBW (<1500 g); VPD, very PD (<32 weeks). LGA, large for gestational age (>90th percentile) 36 ; OI, ovulation induction; PD, preterm delivery (<37 weeks' gestation); postD, post-term delivery (>41 weeks); SGA, small for gestational age (<10th percentile) 36 ; TD, term delivery; VLBW, very LBW (<1500 g); VPD, very PD (<32 weeks).
(singletons/twins), for the outcomes; PD, LBW, and PD with LBW, these results should be treated with caution, because a larger study from more recent births in South Australia may strengthen or weaken any association. Of the maternal covariates, there is one pregnancy observation that may potentially contribute to the observed lower mean gestational age and increase in PD with LBW. Mothers receiving donor insemination had significantly higher prevalence of PIH, which is supported by the Salha et al. study. 21 In an analysis of PIH and PE, Villar et al. concluded that the conditions were related. 39 Data on the incidence of PE, however, were not available from the SAPSC to confirm whether this was also elevated in the donor sperm cohort, as has been reported elsewhere. [18] [19] [20] [21] [22] Given that PE has been associated with PD and fetal growth restriction, 40 which is a function of LBW, an increased incidence of PE could possibly explain the lower mean gestational age and increased incidence of PD with LBW observed in the donor sperm cohort.
Neonates conceived with donated sperm were more likely to be twins than those conceived spontaneously. This was associated with the use of OI as part of the donor insemination program. Overall, OI was associated with a number of adverse perinatal outcomes, but stratification by multiplicity showed that this reflected the elevated occurrence of twins and the only direct effect was a reduced gestational age in twins. OI was also a treatment modality for women with irregular cycles elsewhere in Australia, as part of donor inseminations programs during that period. 20 The stimulant used for OI could adversely influence perinatal outcomes. For example, clomiphene citrate, a commonly used stimulant, has been associated with higher incidences of LBW, 41, 42 PD, 42 and SGA neonates. 41 We did not have sufficient statistical power, however, to analyze outcomes associated with specific drugs.
The absence of adverse perinatal outcomes in donor sperm conceptions suggests that DNA damage may be minimized during cryopreservation of donor semen. Several factors may be influencing this finding.
The extent of DNA damage induced by cryopreservation is influenced by the quality of the sperm, 43, 44 and, considering that one of the criteria for acceptance as a semen donor is good-quality sperm, it would be unsurprising if DNA damage in cryopreserved donor sperm was less than that for cryopreserved sperm from other men. A donor spermatozoa with DNA damage probably has a low likelihood of fertilizing an oocyte following artificial insemination, given that sperm DNA damage contributes to infertility in men. 45 Also, sperm with elevated levels of DNA damage has been associated with reduced pregnancy rates in IVF and ICSI. 46 Furthermore, the oocyte is able to repair small amounts of DNA damage introduced by the spermatazoa. 47 Thus the combination of good-quality sperm from fertile donors, with natural selection of the fittest sperm through artificial insemination rather than specific sperm selected in IVF/ICSI treatment modalities, the oocyte's ability to repair small amounts of DNA damage, and the reduced likelihood of an abnormal embryo achieving implantation, 48 may potentially explain the absence of substantial differences in perinatal outcomes in the donor sperm cohort. The size of the donor sperm cohort, however, means that we cannot rule out the possibility of modest differences that were not detectable as statistically significant. This possibility will be investigated when more recent donor sperm conceptions can be added to the cohort.
The adverse perinatal outcomes observed in donor oocyte neonates, 32, 33 were not mirrored in this donor sperm cohort with the exceptions of lower mean gestational age and PD with LBW. Hypothetically, donor oocyte perinatal outcomes could be worse than those observed for donor sperm neonates because a donor oocyte represents a significant immunological challenge. Novel oocyte antigens are not something a mother would naturally be exposed to, unlike novel sperm antigens, even though both result in increased incidences of PE. More studies are required, however, to confirm or refute the postulation that donor sperm neonates fare better than their donor oocyte counterparts.
These results may be reassuring to clinicians in the counseling of their patients as to the perinatal risks associated with using donated semen. Furthermore, the lack of adverse perinatal outcomes may also be reassuring for any adult person conceived with donated sperm in regard to their probability of developing adultonset diseases such as heart disease and type-2 diabetes mellitus. Due to the sample size of the donor sperm cohort from January 1986 to December 2002, the inclusion of data from subsequent years would be of great benefit to improve statistical power and the reliability of the results observed.
